IT1216751B - Composto tetrazolico antiipercolesterolemico. - Google Patents

Composto tetrazolico antiipercolesterolemico.

Info

Publication number
IT1216751B
IT1216751B IT8819525A IT1952588A IT1216751B IT 1216751 B IT1216751 B IT 1216751B IT 8819525 A IT8819525 A IT 8819525A IT 1952588 A IT1952588 A IT 1952588A IT 1216751 B IT1216751 B IT 1216751B
Authority
IT
Italy
Prior art keywords
hypercholesterolemic
tetrazolic
compound
tetrazolic compound
hypercholesterolemic tetrazolic
Prior art date
Application number
IT8819525A
Other languages
English (en)
Other versions
IT8819525A0 (it
Inventor
John J Wright
Sing Yuen Sit
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of IT8819525A0 publication Critical patent/IT8819525A0/it
Application granted granted Critical
Publication of IT1216751B publication Critical patent/IT1216751B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
IT8819525A 1987-02-25 1988-02-24 Composto tetrazolico antiipercolesterolemico. IT1216751B (it)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1854287A 1987-02-25 1987-02-25
US07/151,513 US4897490A (en) 1987-02-25 1988-02-18 Antihypercholesterolemic tetrazole compounds

Publications (2)

Publication Number Publication Date
IT8819525A0 IT8819525A0 (it) 1988-02-24
IT1216751B true IT1216751B (it) 1990-03-08

Family

ID=26691223

Family Applications (1)

Application Number Title Priority Date Filing Date
IT8819525A IT1216751B (it) 1987-02-25 1988-02-24 Composto tetrazolico antiipercolesterolemico.

Country Status (31)

Country Link
US (1) US4897490A (it)
JP (1) JP2603324B2 (it)
KR (1) KR960001203B1 (it)
CN (1) CN1026110C (it)
AT (1) AT395589B (it)
AU (1) AU1395088A (it)
BE (1) BE1002116A3 (it)
CA (1) CA1328268C (it)
CH (1) CH676848A5 (it)
CS (1) CS271481B2 (it)
DE (1) DE3805801C2 (it)
DK (1) DK174822B1 (it)
EG (1) EG18341A (it)
ES (2) ES2010246A6 (it)
FI (1) FI96601C (it)
FR (1) FR2612924B1 (it)
GR (1) GR1000472B (it)
HU (3) HU204038B (it)
IE (1) IE61619B1 (it)
IL (1) IL85529A (it)
IT (1) IT1216751B (it)
LU (1) LU87144A1 (it)
MX (1) MX9202847A (it)
MY (1) MY103214A (it)
NL (1) NL8800465A (it)
NO (1) NO169438C (it)
NZ (1) NZ223620A (it)
PT (1) PT86820B (it)
SE (1) SE503618C2 (it)
WO (1) WO1988006584A1 (it)
YU (1) YU36388A (it)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3741509A1 (de) * 1987-12-08 1989-06-22 Hoechst Ag Verfahren zur herstellung optisch aktiver 3-desmethylmevalonsaeurederivate sowie zwischenprodukte
US4824959A (en) * 1988-02-18 1989-04-25 Bristol-Myers Company Intermediates for antihypercholesterolemic tetrazole compounds
GB2244706B (en) * 1988-02-18 1992-07-15 Bristol Myers Co Preparation of antihypercholesterolemic tetrazole intermediates
US4870187A (en) * 1988-08-23 1989-09-26 Bristol-Myers Company Antihypercholesterolemic tetrazol-1-yl compounds
US5010205A (en) * 1988-08-23 1991-04-23 Bristol-Myers Company Antihypercholesterolemic tetrazol-1-yl intermediates
US4927944A (en) * 1988-08-25 1990-05-22 Bristol-Myers Company Antihypercholesterolemic nitrile compounds
FI94339C (fi) 1989-07-21 1995-08-25 Warner Lambert Co Menetelmä farmaseuttisesti käyttökelpoisen /R-(R*,R*)/-2-(4-fluorifenyyli)- , -dihydroksi-5-(1-metyylietyyli)-3-fenyyli-4-/(fenyyliamino)karbonyyli/-1H-pyrroli-1-heptaanihapon ja sen farmaseuttisesti hyväksyttävien suolojen valmistamiseksi
US5413935A (en) * 1991-04-24 1995-05-09 E. R. Squibb & Sons, Inc. Process for selecting an enantiomer of a hydroxy lactone using pseudomonas lipase
US5134155A (en) * 1991-08-08 1992-07-28 Ortho Pharmaceutical Corporation Tetrahydroindazole, tetrahydrocyclopentapyrazole, and hexahydrocycloheptapyrazole compounds and their use as HMG-coA reductase inhibitors
US5986095A (en) * 1992-01-06 1999-11-16 E.R. Squibb & Sons, Inc. Enantioselective preparation of halophenyl alcohols and acylates
US5278313A (en) * 1992-03-27 1994-01-11 E. R. Squibb & Sons, Inc. Process for the preparation of 1,3-dioxane derivatives useful in the preparation of HMG-COA reductase inhibitors
US5324662A (en) * 1992-05-15 1994-06-28 E. R. Squibb & Sons, Inc. Stereoselective microbial or enzymatic reduction of 3,5-dioxo esters to 3-hydroxy-5-oxo, 3-oxo-5-hydroxy, and 3,5-dihydroxy esters
US5284957A (en) * 1992-09-03 1994-02-08 Eli Lilly And Company Excitatory amino acid receptor antagonists
JPH06329679A (ja) * 1993-01-20 1994-11-29 Nissan Chem Ind Ltd 光学活性β−アミノアルコキシボラン錯体
CA2137049A1 (en) * 1993-12-15 1995-06-16 John K. Thottathil Amino acid salts of and methods for preparing antihypercholesterolemic tetrazole compounds
DE19714343A1 (de) 1997-04-08 1998-10-15 Bayer Ag Chromatographische Enantiomerentrennung von Lactonen
PT1054860E (pt) * 1997-12-19 2007-06-22 Pfizer Ireland Pharmaceuticals Processo para a síntese 1, 2 dióis
DE10216967A1 (de) * 2002-04-16 2003-11-13 Bayer Ag Verfahren zur Herstellung spezieller aromatischer Aldehyde
EP2178846A1 (en) * 2007-07-12 2010-04-28 Teva Pharmaceutical Industries Ltd. Rosuvastatin intermediates and their preparation
KR101681041B1 (ko) 2015-07-15 2016-12-22 경북대학교병원 ＥＲＲγ 비활성화 리간드로서의 신규한 방향족 고리 화합물 유도체

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4054666A (en) * 1973-03-23 1977-10-18 American Home Products Corporation Compositions and methods of treating immediate hypersensitivity reactions with thiazolyl oxamic acid derivatives
US4160100A (en) * 1973-03-23 1979-07-03 American Home Products Corporation Oxamic acid derivatives
US4013647A (en) * 1976-03-23 1977-03-22 American Home Products Corporation Morpholine containing tetrazole-5-carboxamide derivatives
JPS53147073A (en) * 1977-05-24 1978-12-21 Sankyo Co Ltd Mevalonolactone derivatives
IL60751A (en) * 1979-08-17 1985-04-30 Merck & Co Inc 6-(2'-((substituted phenyl)ethyl and-ethenyl)-4-hydroxy-tetrahydro-2h-pyran-2-one derivatives,their preparation and pharmaceutical compositions containing them
US4375475A (en) * 1979-08-17 1983-03-01 Merck & Co., Inc. Substituted pyranone inhibitors of cholesterol synthesis
US4567289A (en) * 1979-08-17 1986-01-28 Merck & Co., Inc. Substituted pyranone inhibitors of cholesterol synthesis
EP0068038B1 (en) * 1981-06-29 1985-09-25 Merck & Co. Inc. (+)-(4r,6s)-(e)-6-(2-(4'-fluoro-3,3',5-trimethyl-(1,1'-biphenyl)-2-yl)ethenyl)-3,4,5,6-tetrahydro-4-hydroxy-2h-pyran-2-one, a process for preparing and a pharmaceutical composition containing the same
WO1983002131A1 (en) * 1981-12-10 1983-06-23 Willy Bayer Internal combustion engine
AU570021B2 (en) * 1982-11-22 1988-03-03 Novartis Ag Analogs of mevalolactone
US4739073A (en) * 1983-11-04 1988-04-19 Sandoz Pharmaceuticals Corp. Intermediates in the synthesis of indole analogs of mevalonolactone and derivatives thereof
DE3461180D1 (en) * 1983-01-24 1986-12-11 Sandoz Ag Analogs of mevalonolactone and derivatives thereof, processes for their production, pharmaceutical compositions containing them and their use as pharmaceuticals
CA1327360C (en) * 1983-11-14 1994-03-01 William F. Hoffman Oxo-analogs of mevinolin-like antihypercholesterolemic agents
EP0200736B1 (en) * 1984-06-22 1991-04-24 Sandoz Ag Pyrazole analogs of mevalonolactone and derivatives thereof, processes for their production and their use
US4613610A (en) * 1984-06-22 1986-09-23 Sandoz Pharmaceuticals Corp. Cholesterol biosynthesis inhibiting pyrazole analogs of mevalonolactone and its derivatives
US4668794A (en) * 1985-05-22 1987-05-26 Sandoz Pharm. Corp. Intermediate imidazole acrolein analogs
US4621099A (en) * 1985-09-23 1986-11-04 Usv Pharmaceutical Corporation Polyene compounds useful in the treatment of allergic responses
US4681893A (en) * 1986-05-30 1987-07-21 Warner-Lambert Company Trans-6-[2-(3- or 4-carboxamido-substituted pyrrol-1-yl)alkyl]-4-hydroxypyran-2-one inhibitors of cholesterol synthesis
US4678806A (en) * 1986-09-02 1987-07-07 Merck & Co., Inc. Prodrugs of antihypercholesterolemic compounds

Also Published As

Publication number Publication date
ES2026746A6 (es) 1992-05-01
CN88100911A (zh) 1988-09-28
DK97288D0 (da) 1988-02-24
ATA46188A (de) 1992-06-15
JPH01502269A (ja) 1989-08-10
HU900669D0 (en) 1990-06-28
GR1000472B (el) 1992-07-30
SE8800638L (sv) 1988-09-21
IL85529A (en) 1993-01-31
CN1026110C (zh) 1994-10-05
DE3805801C2 (de) 2001-03-01
PT86820B (pt) 1995-03-01
DK97288A (da) 1988-08-26
DK174822B1 (da) 2003-12-08
KR880009947A (ko) 1988-10-06
FI880869A0 (fi) 1988-02-24
NO880809L (no) 1988-08-26
HU203329B (en) 1991-07-29
IE880501L (en) 1988-08-25
SE503618C2 (sv) 1996-07-15
ES2010246A6 (es) 1989-11-01
NZ223620A (en) 1991-07-26
GR880100101A (en) 1988-12-16
SE8800638D0 (sv) 1988-02-24
LU87144A1 (fr) 1988-09-20
FR2612924B1 (fr) 1991-01-11
HUT47259A (en) 1989-02-28
WO1988006584A1 (en) 1988-09-07
IL85529A0 (en) 1988-08-31
BE1002116A3 (fr) 1990-07-10
NO880809D0 (no) 1988-02-24
KR960001203B1 (ko) 1996-01-24
MX9202847A (es) 1992-06-30
NO169438B (no) 1992-03-16
NL8800465A (nl) 1988-09-16
FR2612924A1 (fr) 1988-09-30
CA1328268C (en) 1994-04-05
CH676848A5 (it) 1991-03-15
IT8819525A0 (it) 1988-02-24
YU36388A (en) 1989-10-31
FI96601B (fi) 1996-04-15
CS118088A2 (en) 1989-08-14
IE61619B1 (en) 1994-11-16
FI880869A (fi) 1988-08-26
MY103214A (en) 1993-05-29
PT86820A (pt) 1989-02-28
NO169438C (no) 1992-06-24
FI96601C (fi) 1996-07-25
AT395589B (de) 1993-01-25
HU896737D0 (en) 1990-02-28
HU204038B (en) 1991-11-28
JP2603324B2 (ja) 1997-04-23
DE3805801A1 (de) 1988-09-08
US4897490A (en) 1990-01-30
EG18341A (en) 1993-08-30
CS271481B2 (en) 1990-10-12
HU204516B (en) 1992-01-28
AU1395088A (en) 1988-09-26

Similar Documents

Publication Publication Date Title
BR1100660A (pt) Composto.
DE3850598D1 (de) Substituierte Di-t-butylphenole.
IT1216751B (it) Composto tetrazolico antiipercolesterolemico.
DE68904944D1 (de) Polyalkenylphenolverbindung.
DE3872153D1 (de) 25-hydroxy-vitamin-d3-derivate.
NO892711D0 (no) Sammensetninger.
FI883963A0 (fi) Isoxazol- -karbolinderivat.
NO893775D0 (no) Substituerte tienepyraner.
NO894589D0 (no) Substituerte oksadiaminobutaner.
ATE93512T1 (de) Oximino-aether-verbindungen.
DE3789797D1 (de) Pyrimidinylphenyl-Ester-Verbindung.
DE3875031D1 (de) Substituierte dibenzocycloheptenimine.
DE58907370D1 (de) Substituierte Azolylmethyloxirane.
DE3861208D1 (de) Hydroxyalkyl-triazolyl-derivate.
DE3878192D1 (de) N-phenyltetrahydrophthalimidverbindungen.
DE3866371D1 (de) Diphenylaethylen-derivate.
DE58908619D1 (de) Dicyanobenzanthronverbindungen.
DE3852099D1 (de) Glycidylsulfonamidverbindungen.
NO884360D0 (no) Substituerte 2-metylisoksazolidiner.
TR24177A (tr) Fenoksifenil ikame edilmis tetrazolinonlar.
NO892643D0 (no) Substituerte azacykloheksyl-derivater.
DE3881146T2 (de) Thiazetidin-Derivate.
DE3884482T2 (de) Thiapentanamid-Derivate.
DE3863447D1 (de) Aminoethylphosphinsaeure-derivate.
DE3868364D1 (de) Ucy-1003-derivate.

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970227